UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Phase I study of bryostatin 1 in patients with relapsed non-Hodgkin's lymphoma and chronic lymphocytic leukemia

Journal of clinical oncology, 1998-01, Vol.16 (1), p.56-62

1998

Volltextzugriff (PDF)

Bryostatin 1 down-regulates mdr1 and potentiates vincristine cytotoxicity in diffuse large cell lymphoma xenografts

Clinical cancer research, 1998-05, Vol.4 (5), p.1305-1314

1998

Volltextzugriff (PDF)

Bryostatin 1 induces ubiquitination and proteasome degradation of Bcl-2 in the human acute lymphoblastic leukemia cell line, Reh

International journal of molecular medicine, 2000-02, Vol.5 (2), p.165

2000

Volltextzugriff (PDF)

The Addition of Bryostatin 1 to Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) Chemotherapy Improves Response in a CHOP-resistant Human Diffuse Large Cell Lymphoma Xenograft Model

Clinical cancer research, 2000-12, Vol.6 (12), p.4950-4956

2000

Volltextzugriff (PDF)

Sequential treatment of human chronic lymphocytic leukemia with bryostatin 1 followed by 2-chlorodeoxyadenosine: preclinical studies

Clinical cancer research, 1998-02, Vol.4 (2), p.445-453

1998

Volltextzugriff (PDF)

Bax:Bcl-2 ratio modulation by bryostatin 1 and novel antitubulin agents is important for susceptibility to drug induced apoptosis in the human early pre-B acute lymphoblastic leukemia cell line, Reh

Leukemia research, 1999-10, Vol.23 (10), p.881-888

1999

Volltextzugriff (PDF)

Treatment-induced Expression of Anti-apoptotic Proteins in WSU-CLL, a Human Chronic Lymphocytic Leukemia Cell Line

Journal of drug targeting, 2001, Vol.9 (5), p.329-339

2001

Volltextzugriff (PDF)

Evaluation of combretastatin A-4 prodrug in a non-Hodgkinʼs lymphoma xenograft model: preclinical efficacy

Anti-cancer drugs, 2001-01, Vol.12 (1), p.57-63

2001

Volltextzugriff (PDF)

Sequential Treatment of a Resistant Chronic Lymphocytic Leukemia Patient with Bryostatin 1 Followed by 2-Chlorodeoxyadenosine: Case Report

Clinical cancer research, 2000-04, Vol.6 (4), p.1328-1332

2000

Volltextzugriff (PDF)

Infrared spectroscopic study of bryostatin 1-induced membrane alterations in a B-CLL cell line

Leukemia, 1999-08, Vol.13 (8), p.1273-1280

1999

Volltextzugriff (PDF)

Phase II Trial of Bryostatin 1 in Patients with Relapsed Low-Grade Non-Hodgkin’s Lymphoma and Chronic Lymphocytic Leukemia

Clinical cancer research, 2000-03, Vol.6 (3), p.825

2000

Volltextzugriff (PDF)

Phase II study of bryostatin 1 in patients with relapsed multiple myeloma

Investigational new drugs, 2001-01, Vol.19 (3), p.245-247

2001

Volltextzugriff (PDF)

Clonal preservation of human pancreatic cell line derived from primary pancreatic adenocarcinoma

Pancreas, 1999-11, Vol.19 (4), p.353-361

1999

Volltextzugriff (PDF)

Lymphomas: MR imaging contrast characteristics with clinical-pathologic correlations

Radiology, 1990-10, Vol.177 (1), p.209-216

1990

Volltextzugriff (PDF)

Detection of intracytoplasmic immunoglobulin by flow cytometry in B- cell malignancies

The journal of histochemistry and cytochemistry, 1989-01, Vol.37 (1), p.83-89

1989

Volltextzugriff (PDF)

Bryostatin 1-induced modulation of nucleoside transporters and 2-chlorodeoxyadenosine influx in WSU-CLL cells

International journal of molecular medicine, 2000-04, Vol.5 (4), p.341

2000

Volltextzugriff (PDF)

Similarities between the sensitivity to 2-chlorodeoxyadenosine of lymphocytes from CLL patients and bryostatin 1-treated WSU-CLL cells: an infrared spectroscopic study

Cancer letters, 1998-05, Vol.127 (1), p.185-193

1998

Volltextzugriff (PDF)

HEAVY METALS TREATED SOIL EFFECTS ON THE CONCENTRATION OF CHLOROPHYLL A, B, AND MINERAL ELEMENTS IN ALGAE

SABRAO journal of breeding and genetics, 2023-08, Vol.55 (4), p.1332-1341

AL-KATIB, M.A.

2023

Volltextzugriff (PDF)

Non-Hodgkin's Lymphoma: An analysis of the Metropolitan Detroit SEER Database

Cancer investigation, 2000, Vol.18 (4), p.303-308

2000

Volltextzugriff (PDF)

Treatment of a de novo fludarabine resistant-CLL xenograft model with bryostatin 1 followed by fludarabine

International journal of oncology, 1999-05, Vol.14 (5), p.945

1999

Volltextzugriff (PDF)

Effects of Combretastatin A-4 prodrug against a panel of malignant human B-lymphoid cell lines

Anti-cancer drugs, 2000-06, Vol.11 (5), p.385-392

2000

Volltextzugriff (PDF)

Evidence for Clonal Disease by Magnetic Resonance Imaging in Patients With Hypoplastic Marrow Disorders

Blood, 1991-12, Vol.78 (11), p.2872-2879

1991

Volltextzugriff (PDF)

Unintended target effect of anti-BCL-2 DNAi

Cancer management and research, 2017-01, Vol.9, p.427-432

2017

Volltextzugriff (PDF)

Modulation of cIAP-1 by Novel Antitubulin Agents When Combined with Bryostatin 1 Results in Increased Apoptosis in the Human Early Pre-B Acute Lymphoblastic Leukemia Cell Line Reh

Biochemical and biophysical research communications, 1999-12, Vol.266 (1), p.76-80

1999

Volltextzugriff (PDF)

Combretastatin-A4 Prodrug Induces Mitotic Catastrophe in Chronic Lymphocytic Leukemia Cell Line Independent of Caspase Activation and Poly(ADP-ribose) Polymerase Cleavage

Clinical cancer research, 2002-08, Vol.8 (8), p.2735-2741

2002

Volltextzugriff (PDF)

1 – 25 von 178

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(153)
Mit Volltextzugriff
(154)

Publikationsform

Sprache

Englisch
(177)
Arabisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Phase I study of bryostatin 1 in patients with relapsed non-Hodgkin's lymphoma and chronic lymphocytic leukemia

Bryostatin 1 down-regulates mdr1 and potentiates vincristine cytotoxicity in diffuse large cell lymphoma xenografts

Bryostatin 1 induces ubiquitination and proteasome degradation of Bcl-2 in the human acute lymphoblastic leukemia cell line, Reh

The Addition of Bryostatin 1 to Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) Chemotherapy Improves Response in a CHOP-resistant Human Diffuse Large Cell Lymphoma Xenograft Model

Sequential treatment of human chronic lymphocytic leukemia with bryostatin 1 followed by 2-chlorodeoxyadenosine: preclinical studies

Bax:Bcl-2 ratio modulation by bryostatin 1 and novel antitubulin agents is important for susceptibility to drug induced apoptosis in the human early pre-B acute lymphoblastic leukemia cell line, Reh

Treatment-induced Expression of Anti-apoptotic Proteins in WSU-CLL, a Human Chronic Lymphocytic Leukemia Cell Line

Evaluation of combretastatin A-4 prodrug in a non-Hodgkinʼs lymphoma xenograft model: preclinical efficacy

Sequential Treatment of a Resistant Chronic Lymphocytic Leukemia Patient with Bryostatin 1 Followed by 2-Chlorodeoxyadenosine: Case Report

Infrared spectroscopic study of bryostatin 1-induced membrane alterations in a B-CLL cell line

Phase II Trial of Bryostatin 1 in Patients with Relapsed Low-Grade Non-Hodgkin’s Lymphoma and Chronic Lymphocytic Leukemia

Phase II study of bryostatin 1 in patients with relapsed multiple myeloma

Clonal preservation of human pancreatic cell line derived from primary pancreatic adenocarcinoma

Lymphomas: MR imaging contrast characteristics with clinical-pathologic correlations

Detection of intracytoplasmic immunoglobulin by flow cytometry in B- cell malignancies

Bryostatin 1-induced modulation of nucleoside transporters and 2-chlorodeoxyadenosine influx in WSU-CLL cells

Similarities between the sensitivity to 2-chlorodeoxyadenosine of lymphocytes from CLL patients and bryostatin 1-treated WSU-CLL cells: an infrared spectroscopic study

HEAVY METALS TREATED SOIL EFFECTS ON THE CONCENTRATION OF CHLOROPHYLL A, B, AND MINERAL ELEMENTS IN ALGAE

Non-Hodgkin's Lymphoma: An analysis of the Metropolitan Detroit SEER Database

Treatment of a de novo fludarabine resistant-CLL xenograft model with bryostatin 1 followed by fludarabine

Effects of Combretastatin A-4 prodrug against a panel of malignant human B-lymphoid cell lines

Evidence for Clonal Disease by Magnetic Resonance Imaging in Patients With Hypoplastic Marrow Disorders

Unintended target effect of anti-BCL-2 DNAi

Modulation of cIAP-1 by Novel Antitubulin Agents When Combined with Bryostatin 1 Results in Increased Apoptosis in the Human Early Pre-B Acute Lymphoblastic Leukemia Cell Line Reh

Combretastatin-A4 Prodrug Induces Mitotic Catastrophe in Chronic Lymphocytic Leukemia Cell Line Independent of Caspase Activation and Poly(ADP-ribose) Polymerase Cleavage

Suchergebnisse filtern